Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Chan Zuckerberg Initiative announces project to end human disease

Sep 22, 2023 - businessinsider.com
Priscilla Chan and Mark Zuckerberg have announced plans to eradicate human disease by 2100 through the development of a computing system. The system, which will use 1,000 GPUs, will catalog cells and predict their behavior when diseased, potentially leading to new discoveries that could eliminate human disease. The Chan Zuckerberg Initiative plans to have the product running by 2024, though the cost is undisclosed and could be substantial due to the high demand and low supply of the computer parts needed.

The initiative will make the tool publicly available so researchers can collaboratively use it for new discoveries. This could level the playing field for researchers who lack equal access to computing power for biotechnology research. The AI techniques used in this project are similar to those used in Meta's AI tool, ESMFold, and the large language models used in AlphaFold and ChatGPT.

Key takeaways:

  • Priscilla Chan and Mark Zuckerberg announced plans to develop a computing system that can help eradicate human disease by 2100. The system will use AI to catalog cells and predict their behavior when diseased.
  • The Chan Zuckerberg Initiative plans to have their product running by 2024. The system will be made of 1,000 graphics processing units to visually analyze both healthy and diseased cells from databases.
  • The initiative aims to make the tool available to the public so that researchers can use it collaboratively to make new discoveries, potentially leveling the playing field for researchers who lack equal access to computing power.
  • The AI techniques used in this project are similar to those used in a previous tool developed by Meta, called ESMFold, which efficiently predicts the shape of proteins using AI. The same type of program, a large language model, will be used in the new proposal.
View Full Article

Comments (0)

Be the first to comment!